The effectiveness of alteplase and urokinase in restoring adequate hemodialysis blood-flow rates was examined. A retrospective review of the medical records of hemodialysis patients with central ...
In 2001, the US Food and Drug Administration approved recombinant tissue plasminogen activator (alteplase, Cathflo Activase) to reestablish patency of central catheters occluded, presumably, by a ...
Some variability in the activity assay existed; however, this variance was within our definition of activity for the assay and was consistent with that reported in other studies utilizing this assay.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback